Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...
Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.
Standing behind this new AgTech revolution is the goal to ensure food security and reduce hunger worldwide. One of the ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
A group of gun owners, stores and firearms groups won an injunction against the attorney general of Maine, who may not ...
9h
Medpage Today on MSNWhat's the Better Option for High-Risk Prostate Cancer -- Radiation or Surgery?SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...
A clinical trial led by researchers at UT Southwestern Medical Center in Dallas could help bring an experimental treatment ...
13h
GlobalData on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...
B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results